Get started
Author

Mustafa Alperen Tunç

Observed names: Mustafa A. Tunç, Mustafa Alperen TUNÇ, Mustafa Alperen Tunc
ORCID: 0000-0002-1537-3032
Observed ORCID: 0000-0002-1537-3032
OpenAlex ID: A5055265293
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
2025 · Nadiye Sever, Fatih Şimşek, et al. · Journal of Clinical Medicine · 16
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
2025 · Ali Kaan Güren, Murad Guliyev, et al. · Journal of Clinical Medicine · 11
PDF
Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer
2025 · Nurullah İlhan, Süleyman Baş, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Immune checkpoint inhibitors and myocarditis–myositis–myasthenia gravis overlap: a FAERS pharmacovigilance study with time-to-onset characterization
2026 · Burak Pacaci, Bilal Yildirim, et al. · Frontiers in Pharmacology · 3
PDF
The Role of Baseline PET/CT Parameters in Predicting Treatment Response in Patients with Locally Advanced Rectal Cancer Undergoing Total Neoadjuvant Therapy
2025 · Ali Kaan Güren, Zilan Başkan, et al. · Medicina · 3
PDF
Acquired CD74–ROS1 fusion–mediated osimertinib resistance successfully treated with osimertinib and crizotinib: a case report
2026 · Ali Kaan Güren, Erkam Kocaaslan, et al. · Journal of Chemotherapy · 2
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma
2026 · Burak Paçacı, Erkam Kocaaslan, et al. · Journal of Clinical Medicine · 2
PDF
Comparison of paclitaxel and docetaxel in dual HER2 blockade: efficacy and safety in neoadjuvant treatment of HER2-positive breast cancer
2025 · Ezgi Turkoglu, Goncagul Akdag Topal, et al. · Breast Cancer Research and Treatment · 2
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns
2026 · Abdussamet Çelebi, Nur Aybüke Bircan, et al. · BMC Health Services Research · 1
Capecitabine-induced pneumonitis: a rare case report and literature review
2026 · Mustafa A. Tunç, Ali K. Güren, et al. · Anti-Cancer Drugs · 1
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
2026 · Erkam Kocaaslan, Ali Kaan Güren, et al. · Journal of Clinical Medicine · 1
PDF
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab
2026 · Erkam Kocaaslan, Ali Kaan Güren, et al. · Medicina · 1
PDF
Impact of Sarcopenia and Osteopenia on Prognosis in Metastatic Biliary Tract Cancer: A Single Center Experience
2025 · Nadiye Sever, Emil Yunusov, et al. · Nutrition and Cancer · 1
Efficacy and Safety of the Topotecan–Cyclophosphamide Regimen in Adult Metastatic Ewing Sarcoma: A Large, Multicenter, Real-World Study
2025 · Salih Tunbekici, Haydar Cagatay Yuksel, et al. · Cancers · 1
PDF
The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis
2025 · Nadiye Sever, Sedat Yıldırım, et al. · Medicina · 1
PDF
Real-world plasma-based next-generation sequencing findings in metastatic lung adenocarcinoma: a single-center retrospective study
2026 · Erkam Kocaaslan, Emir Göçer, et al. · Marmara medical journal
PDF
Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor–Related Colitis With Vedolizumab: A Case Report and Literature Review
2026 · Fırat Akagündüz, Emir Göçer, et al. · Journal of Enterocolitis
PDF
Prognostic Value of a Seven-Factor Risk Stratification System in T3N0 Colon Cancer: A Single-Center Retrospective Study
2026 · Abdussamet Çelebi, Eren Meral, et al. · Medicina
Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors
2026 · Ezgi Çoban, Atilla Eren Kurt, et al. · Journal of Clinical Medicine
Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Cohort Study
2026 · Ahmet Demirel, Bora İnceöz, et al. · Journal of Clinical Medicine
Prognostic Significance of Postoperative Edema in Surgically Treated Non-glioblastoma Diffuse Glioma
2026 · Erkam KOCAASLAN, Gülşah ÖZDEN, et al. · Journal of Oncological Sciences
PDF
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies
2026 · Mustafa Alperen Tunç, Ali Kaan Güren, et al. · Journal of Clinical Medicine
PDF
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score
2026 · Burak Pacaci, Buket Erkan Ozmarasali, et al. · BMC Cancer
Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study
2026 · Ozlem Candan¹, Narmin Naghizada, et al. · Frontiers in Medicine
PDF
Comparative overall survival in T4N0 and T2-3N1 non-metastatic colon cancer: a retrospective cohort study
2026 · Fırat Akagunduz, Ali Kaan Güren, et al. · Annals of Saudi Medicine
Works count: 31
Citation count: 50
H-index: 3
I10-index: 2
Year
Topic
Type